Xinbang Pharmaceutical

Sincerity and Integrity, Unity for the Nation's Prosperity, Health for the People, Development for Livelihood
Guizhou Xinbang Pharmaceutical Co., Ltd. was established in January 1995, registered in Luodian County, Guizhou Province, with its management headquarters in Guiyang City. In April 2010, the company was successfully listed on the Shenzhen Stock Exchange.
Currently, the company has a registered capital of 1.667 billion yuan, total assets of 10.854 billion yuan, net assets attributable to shareholders of the listed company of 4.967 billion yuan, over 50 holding subsidiaries, and nearly 7,000 employees. It has developed into a full-industry-chain enterprise group integrating medical services, pharmaceutical distribution, and pharmaceutical manufacturing. In 2018, the company achieved operating revenue of 6.58 billion yuan, a year-on-year increase of 9.63%. Over the past three years, the company has paid nearly 920 million yuan in taxes, with steady growth in operating performance.
The company owns several medical institutions, including Guizhou Provincial Cancer Hospital, Baiyun Hospital Affiliated to Guizhou Medical University, Wudang Hospital Affiliated to Guizhou Medical University, Guiyi Anshun Hospital, Renhuai Xinzhaoyang Hospital, Liuzhi Boda Hospital, Liupanshui Anju Hospital, and Daozhen County Traditional Chinese Medicine Hospital, distributed in Guiyang, Zunyi, Anshun, Liupanshui, and other locations, with nearly 6,000 beds. Through the "Guiyi Cloud" and "Zunyi Cloud Hospital" internet medical service platforms, the company has achieved a comprehensive online and offline medical layout.
In the pharmaceutical distribution segment, the company has over 20 distribution companies, including Kekai Pharmaceutical, Zhuoda Pharmaceutical, Xinbang Pharmaceutical, Kekai Pharmacy, Xindali Biotechnology, and Zhongkang Zeai Medical Devices. These companies primarily engage in the sales and distribution of pharmaceuticals and medical devices, with tens of thousands of product varieties, basically covering the procurement needs of top-tier hospitals. They have formed a distribution network centered in Guiyang, covering key regions such as Qiannan, Zunyi, Bijie, and Tongren, and radiating to the entire province.
In the pharmaceutical manufacturing segment, the company's business covers Chinese herbal medicine cultivation, production and sales of TCM decoction pieces and proprietary Chinese medicines, and research, development, production, and sales of peptide drugs and diagnostic reagents, forming a closed-loop industrial chain.
In terms of proprietary Chinese medicines, the company has 5 GMP production lines, 48 national drug approval numbers, 4 national high-quality and competitive-price products, 2 protected traditional Chinese medicine varieties, and 8 exclusive varieties. Flagship products such as Maixuekang Capsules and Yixinshu Capsules have repeatedly won the title of "Guizhou Province Famous Brand Products." The company has established an office partner model with sales managers at its core, creating a three-dimensional marketing system.
In the biopharmaceutical field, subsidiary Zhongtai Biochemical has passed the U.S. FDA audits four consecutive times with zero deficiencies, and its products are exported to all major continents. It possesses leading peptide innovation technology and is a long-term stable peptide partner for top 10 international pharmaceutical companies and world-renowned scientific research institutions. Its diagnostic reagent products have passed both U.S. FDA and EU CE certifications, with a rich in vitro diagnostic reagent product line covering drug abuse, pregnancy, myocardial, tumor, and infectious disease testing.
Adhering to the corporate philosophy of "Sincerity and Integrity, Unity for the Nation's Prosperity, Health for the People, Development for Livelihood," and practicing the core values of "Honest Cooperation, Practical Innovation, and Pursuit of Results," the company insists on honest management and innovative development. It has repeatedly been listed in the China Listed Companies Reputation List, receiving titles such as "Most Growth-Oriented Listed Company" and "Best Business Model Listed Company," and has consecutively been included in the Guizhou Province "Double Top 100" list. In 2017, it ranked 39th in the "Top 100 Enterprises" and 4th in the "Top 100 Private Enterprises"; in 2018, it ranked 36th and 3rd respectively, continuing to lead the province's pharmaceutical industry.
People are fully utilized, and resources are fully used. At Xinbang, we will provide you with competitive salary and benefits, broad personal development space, and a comprehensive training mechanism. At Xinbang, you will gain not only salary and self-improvement but also the joy of work and the brilliance of life!
Thank you for your attention and trust in Xinbang Pharmaceutical. We believe that with you, we will usher in a more brilliant tomorrow!
We sincerely look forward to your joining!
Contact number: ***********/88660272